loading
Precedente Chiudi:
$3.25
Aprire:
$2.8
Volume 24 ore:
451.36K
Relative Volume:
1.37
Capitalizzazione di mercato:
$8.71M
Reddito:
$556.00K
Utile/perdita netta:
$-5.28M
Rapporto P/E:
-1.2126
EPS:
-2.14
Flusso di cassa netto:
$-6.23M
1 W Prestazione:
+10.90%
1M Prestazione:
+1.96%
6M Prestazione:
-4.60%
1 anno Prestazione:
-5.64%
Intervallo 1D:
Value
$2.50
$2.83
Intervallo di 1 settimana:
Value
$2.30
$3.76
Portata 52W:
Value
$1.27
$9.4699

Cyclerion Therapeutics Inc Stock (CYCN) Company Profile

Name
Nome
Cyclerion Therapeutics Inc
Name
Telefono
617-621-7722
Name
Indirizzo
301 BINNEY STREET, CAMBRIDGE, MA
Name
Dipendente
1
Name
Cinguettio
@Cyclerion
Name
Prossima data di guadagno
2024-12-15
Name
Ultimi documenti SEC
Name
CYCN's Discussions on Twitter

Confronta CYCN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CYCN
Cyclerion Therapeutics Inc
2.61 10.41M 556.00K -5.28M -6.23M -2.14
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
380.31 96.56B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
447.62 60.08B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
555.25 61.15B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
708.64 44.66B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
328.54 36.23B 3.81B -644.79M -669.77M -6.24

Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-10-20 Iniziato Truist Buy
2021-09-24 Iniziato Cantor Fitzgerald Overweight
2019-06-03 Iniziato Credit Suisse Neutral

Cyclerion Therapeutics Inc Borsa (CYCN) Ultime notizie

pulisher
10:48 AM

Real time scanner hits for Cyclerion Therapeutics Inc. explainedInsider Buying & Free Verified High Yield Trade Plans - newser.com

10:48 AM
pulisher
Sep 24, 2025

Cyclerion Therapeutics’ Licence Move: Boost or Bust? - StocksToTrade

Sep 24, 2025
pulisher
Sep 24, 2025

Hengrui, Glenmark ink ADC deal; Rome Therapeutics to seek ‘strategic options’ - Endpoints News

Sep 24, 2025
pulisher
Sep 24, 2025

Why Is Cyclerion Stock Surging In Pre-market Trade? - Nasdaq

Sep 24, 2025
pulisher
Sep 24, 2025

Full technical analysis of Cyclerion Therapeutics Inc. stockPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com

Sep 24, 2025
pulisher
Sep 24, 2025

Cyclerion Therapeutics jumps on MIT deal to develop depression drug - TradingView

Sep 24, 2025
pulisher
Sep 23, 2025

Why Did Cyclerion Therapeutics Stock Surge Nearly 50% After-Hours Today? - MSN

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion signs MIT license for treatment-resistant depression program By Investing.com - Investing.com Australia

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion signs MIT license for treatment-resistant depression program - Investing.com

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Announces Transformational Relaunch As A Neuropsychiatric Company - TradingView

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Therapeutics Enters License Agreement With MIT to Relaunch as Neuropsychiatric Firm - MarketScreener

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Therapeutics Relaunches with Neuropsychiatric Focus - TipRanks

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Therapeutics (CYCN) Secures MIT Licensing for Strategi - GuruFocus

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Therapeutics Announces Strategic Relaunch and Licensing Agreement with MIT to Address Treatment-Resistant Depression - Quiver Quantitative

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion stock soars after MIT licensing deal to relaunch company - Investing.com

Sep 23, 2025
pulisher
Sep 23, 2025

Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company - GlobeNewswire

Sep 23, 2025
pulisher
Sep 23, 2025

Insiders Rewarded With US$55k Addition To Investment As Cyclerion Therapeutics Stock Hits US$7.6m - simplywall.st

Sep 23, 2025
pulisher
Sep 23, 2025

Best data tools to analyze Cyclerion Therapeutics Inc. stockWeekly Risk Report & Accurate Technical Buy Alerts - newser.com

Sep 23, 2025
pulisher
Sep 22, 2025

Cyclerion Therapeutics Inc. stock volume spike explainedMarket Trend Review & Growth Focused Stock Reports - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

How to use a screener to detect Cyclerion Therapeutics Inc. breakoutsStock Surge & Momentum Based Trading Signals - newser.com

Sep 22, 2025
pulisher
Sep 20, 2025

What MACD signals say about Cyclerion Therapeutics Inc.Trend Reversal & Stepwise Trade Execution Plans - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Multi asset correlation models including Cyclerion Therapeutics Inc.July 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Quarterly Earnings: Is Cyclerion Therapeutics Incs growth already priced inShort Setup & Technical Pattern Alert System - خودرو بانک

Sep 20, 2025
pulisher
Sep 19, 2025

Using RSI to spot recovery in Cyclerion Therapeutics Inc.2025 Price Momentum & Short-Term Trading Alerts - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Will Cyclerion Therapeutics Inc. bounce back from current supportJuly 2025 Retail & Smart Allocation Stock Tips - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Strategies to average down on Cyclerion Therapeutics Inc.Inflation Watch & Target Return Focused Picks - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Will Cyclerion Therapeutics Inc. stock recover after recent dropJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Exit strategy if you’re trapped in Cyclerion Therapeutics Inc.July 2025 PostEarnings & Real-Time Volume Trigger Notifications - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Update Recap: Can Cyclerion Therapeutics Inc deliver alphaJuly 2025 Momentum & Community Driven Trade Alerts - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Buyback Watch: Should I invest in Cyclerion Therapeutics Inc before earningsWeekly Market Outlook & AI Forecasted Entry/Exit Points - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Aug Retail: Does Cyclerion Therapeutics Inc meet Warren Buffetts criteria2025 Trade Ideas & Community Verified Watchlist Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Buyback Watch: Is Cyclerion Therapeutics Inc a good ESG investmentQuarterly Investment Review & Reliable Intraday Trade Alerts - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Is Cyclerion Therapeutics Inc stock a good pick for beginnersWeekly Profit Recap & Daily Price Action Insights - خودرو بانک

Sep 18, 2025
pulisher
Sep 17, 2025

Aug Volume: Will Cyclerion Therapeutics Inc. benefit from geopolitical trends2025 Earnings Surprises & Low Risk Entry Point Tips - خودرو بانک

Sep 17, 2025
pulisher
Sep 16, 2025

Aug Volume: Is Cyclerion Therapeutics Inc stock a good pick for beginnersJuly 2025 Reactions & Verified Entry Point Detection - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Aug Rallies: What analysts say about Cyclerion Therapeutics Inc. stock2025 Momentum Check & Free High Accuracy Swing Entry Alerts - khodrobank.com

Sep 15, 2025
pulisher
Sep 15, 2025

Momentum Shift: What is the target price for Cyclerion Therapeutics Inc stockWeekly Investment Report & Free Fast Gain Swing Trade Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Using economic indicators to assess Cyclerion Therapeutics Inc. potential2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com

Sep 15, 2025
pulisher
Sep 15, 2025

Is this a good reentry point in Cyclerion Therapeutics Inc.Weekly Gains Report & AI Driven Price Forecasts - newser.com

Sep 15, 2025
pulisher
Sep 14, 2025

Will Cyclerion Therapeutics Inc. price bounce be sustainableMarket Growth Summary & Short-Term Trading Opportunity Alerts - newser.com

Sep 14, 2025

Cyclerion Therapeutics Inc Azioni (CYCN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.33
price down icon 0.88%
$81.12
price down icon 3.56%
$28.86
price down icon 1.95%
$98.32
price down icon 1.43%
$135.67
price down icon 3.61%
biotechnology ONC
$328.54
price down icon 0.43%
Capitalizzazione:     |  Volume (24 ore):